Four interactions signaled through ITGA9 in myeloid cells, which can activate FAK, MAPK, and NFκB pathways [94–96], promoting a pro-tumor macrophage phenotype that was downregulated post-treatment. The gene discussed is PTK2; the disease is neoplasm.